![](https://d3ilqtpdwi981i.cloudfront.net/DRUROE57xYrvt2DEj_2UR24YSdI=/0x36:371x516/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/e2/76/00/e27600df-a0ba-47fe-880b-58da33accc1a/BHSF%20Logo.png)
Article
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
JAMA Oncology
Publication Date
10-1-2018
Content Type
application/pdf
PubMed ID:
29955793
Citation Information
JAMA Oncol (2018) 4(10):1405-1409